Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Schedule of financial assets and liabilities measured on a recurring basis

	2019
	Level 1		Level 2		Level 3		Fair Value		Carrying Value
Liabilities
Contingent Purchase Price Payable (1)	$	-	$	-	$	6,720,000	$	6,720,000	$	6,720,000

	2018
	Level 1		Level 2		Level 3		Fair Value		Carrying Value
Liabilities
Contingent Purchase Price Payable (1)	$	-	$	-	$	2,365,000	$	2,365,000	$	2,365,000

(1) The contingent consideration is based off achieving certain revenue milestones in each of the next two years. The Geometric-Brownian motion analysis was used to generate spot prices for use in an option pricing model. For 2018, the hypothetical spot prices were simulated using a monte carlo simulation utilizing 2018 revenue as a base and revenue volatility of 37%. The risk-free rate of return and terms utilized were 2.89% and 1.46-2.46, respectively, and expected volatility was 35%. For 2019, the hypothetical spot prices were simulated using a monte carlo simulation utilizing 2020 and 2021 revenue projections and revenue volatility of 40%. The risk-free rate of return and terms utilized were 1.40% and 1 -2 years, respectively, and expected volatility was 40%.

Schedule of changes in fair value of the Company’s Level 3 financial instruments

	Amount
Balance December 31, 2017	$	-
Contingent consideration liability recorded as the result of the CareSpeak Communications acquisition (see note 3)		2,365,000
Balance December 31, 2018		2,365,000
Increase in fair value of CareSpeak Communications contingent consideration		635,000
Contingent consideration liability recorded as the result of the RMDY Health, Inc. acquisition (see note 3)		3,720,000
Balance December 31, 2019	$	6,720,000

Schedule of expected dividends

	2019			2018
Expected dividend yield		0	%		0	%
Risk free interest rate		1.51% - 2.37	%		1.96% - 2.84	%
Expected option term		3.5 years			3.5 - 5 years
Turnover/forfeiture rate		0	%		0	%
Expected volatility		64% - 67	%		64% - 66	%

Schedule of weighted average shares outstanding and the basic and diluted earnings per common share

	Net (Loss)			Shares		Per Share Amount
Year ended December 31, 2019
Basic EPS	$	(3,142,576	)		13,387,863	$	(0.23	)
Diluted EPS	$	(3,142,576	)		13,387,863	$	(0.23	)

	Net Income		Shares		Per Share Amount
Year ended December 31, 2018:
Basic EPS	$	226,344		10,832,209	$	0.02
Effect of dilutive stock options and warrants				1,030,782
Diluted EPS	$	226,344		11,862,991	$	0.02